US Patent 9579366 Recombinant human NaGlu protein and uses thereof
Patent 9579366 was granted and assigned to Alexion Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9579366 Recombinant human NaGlu protein and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.